Abstract
Background: Periosteal osteosarcoma is an uncommon variant of osteosarcoma which constitutes less than 2% of all osteosarcomas. Whereas adequate surgical excision remains the cornerstone of treatment, the role of chemotherapy in this tumor is still unclear. Existing literature contains very few single center studies on the outcomes for periosteal osteosarcomas and any additional information will help in better understanding of these uncommon lesions. This study aims to evaluate the oncologic and functional outcomes of treatment of periosteal osteosarcoma treated at our institute.
Materials and Methods: A retrospective analysis of 18 cases of periosteal osteosarcoma treated between January 2001 and December 2010 was carried out. There were 12 males and 6 females. The mean age at presentation was 16.3 years (range 5–26 years). Tibia and femur were the most common sites (n = 8). 16 of 18 patients received chemotherapy, 16 had limb sparing resection, one had an amputation and one had rotationplasty. Of the 16 patients with limb salvage, conventional wide excision was done in 11 cases. In 5 cases tumor was excised with hemicortical excision. Of the 11 cases treated with wide excisions, 4 patients underwent an osteoarticular resection and in 7 patients a joint preserving segmental intercalary resection was done.
Results: All patients were available for followup. Surgical margins were free in all patients. A good response to chemotherapy was seen in 4/11 cases and poor in 6/11 cases. In one case the histological response was not discernible due to predominant chondromyxoid nature of the tumor. The median followup was 61 months (range: 18–130 months). There were two local recurrences (11%) at 9 and 18 months postsurgery. Pulmonary metastasis subsequently occurred in 4 cases (22%). Fourteen patients are currently alive and continuously disease free. Disease free survival at 5 years was 77.8% and overall survival (OVS) was 83.3%. Patients without marrow involvement had a better OVS at 5 years when compared with patients with marrow involvement (90% vs. 75%) (P = 0.23).
Conclusion: Surgical excision remains the mainstay of treatment. Intramedullary involvement may suggest aggressive disease biology. The role of chemotherapy is still debatable and multicenter studies are needed to provide guidelines.
Similar content being viewed by others
References
Fletcher DM, Unni K, Mertens F, editors. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.
Rose PS, Dickey ID, Wenger DE, Unni KK, Sim FH. Periosteal osteosarcoma: Long term outcome and risk of late recurrence. Clin Orthop Relat Res 2006;453:314–7.
Lichtenstein L. Tumors of periosteal origin. Cancer 1955;8:1060–9.
Unni KK, Dahlin DC, Beabout JW. Periosteal osteogenic sarcoma. Cancer 1976;37:2476–85.
Ewing J. A review of the classification of bone tumours. Bull Am Coll Surg 1939;24:290–5.
Spjut HJ, Ayala AG, de Santos LA, Murray JA. Periosteal osteosarcoma. In: Management of Primary Bone and Soft Tissue Tumors. Chicago, IL: Year Book Medical Publishers; 1977. p. 79–95.
Hall RB, Robinson LH, Malawar MM, Dunham WK. Periosteal osteosarcoma. Cancer 1985;55:165–71.
Cesari M, Alberghini M, Vanel D, Palmerini E, Staals EL, Longhi A, et al. Periosteal osteosarcoma: A single-institution experience. Cancer 2011;117:1731–5.
Grimer RJ, Bielack S, Flege S, Cannon SR, Foleras G, Andreeff I, et al. Periosteal osteosarcoma: A European review of outcome. Eur J Cancer 2005;41:2806–11.
Huvos AG. Osteogenic sarcoma: Pathologic assessment of preoperative (neoadjuvant) chemotherapy. In: Bone Tumors: Diagnosis, Treatment, and Prognosis. 2nd ed. Philadelphia: W. B. Saunders; 1991. p. 122–8.
Campanacci M, editor. Bone and Soft Tissue Tumours. Wien: Springer Verlag; 1999.
Revell MP, Deshmukh N, Grimer RJ, Carter SR, Tillman RM. Periosteal osteosarcoma: A review of 17 cases with mean followup of 52 months. Sarcoma 2002;6:123–30.
Bertoni F, Boriani S, Laus M, Campanacci M. Periosteal chondrosarcoma and periosteal osteosarcoma. Two distinct entities. Periosteal chondrosarcoma and periosteal osteosarcoma 1982;64:370–6.
Ritts GD, Pritchard DJ, Unni KK, Beabout JW, Eckardt JJ. Periosteal osteosarcoma. Clin Orthop Relat Res 1987;219:299–307.
Rasquinha VJ, Zambakidis C, Pringle JAS, Saifuddin A, Briggs TWR, Cannon SR. Periosteal osteosarcoma. J Bone Jointt Surg 1999;81B (Suppl II):186.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gulia, A., Puri, A., Pruthi, M. et al. Oncological and functional outcome of periosteal osteosarcoma. IJOO 48, 279–284 (2014). https://doi.org/10.4103/0019-5413.132518
Published:
Issue Date:
DOI: https://doi.org/10.4103/0019-5413.132518